drugset / Trial / NCT00829257

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

NCT00829257

Phase 4 Completed 15 enrolled University of Dundee
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to establish whether addition of extra-fine particle steroid inhalers achieve additional suppression of small airways inflammation when added to 'standard' Fluticasone/Salmeterol combination therapy in refractory asthma.

Timeline

Start
2009-01
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 250 ug Inhaled
Subject HFA-BDP Unknown 200 ug Inhaled
Background Fluticasone/Salmeterol Unknown Inhaled

Indications